Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Stanley CA, et al. Advances in diagnosis and treatment of hyperinsulinism in infants and children. J Clin Endocrinol Metab. 2002;87:4857–9.
2. De Leon DD, Stanley CA, et al. Mechanism of disease: advances in diagnosis and treatment of hyperinsulinism in neonates. Nat Clin Pract Endocrinol Metab. 2007;3:57–8.
3. Yamada Y, Kitayama K, Oyachi M, Higuchi S, Kawakita R, Kanamori Y, Yorifuji T, et al. Nationwide survey of endogenous hyperinsulinemic hypoglycemia in Japan (2017–2018): congenital hyperinsulinism, insulinoma, non-insulinoma pancreatogenous hypoglycemia syndrome and insulin autoimmune syndrome (Hirata’s disease). J Diabetes Investig. 2020;11:554–63.
4. Kawakita R, Sugimine H, Nagai S, et al. Clinical characteristics of congenital hyperinsulinemic hypoglycemia in infant: a nationwide epidemiological survey in Japan. J Jpn Pediatr Soc. 2011;115:563–9.
5. Yorifuji T, Horikawa R, Hasegawa T, et al. Clinical practice guidelines for congenital hyperinsulinism. Clin Pediatr Endcrinol. 2017;26:127–52.